The Department of Pharmaceuticals (DoP) has revised the guidelines of the production linked incentive (PLI) schemes for promotion of bulk drugs and medical devices, revising the provisions related to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback